{
    "relation": [
        [
            "Feature key",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei",
            "Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.More...Alternative sequencei"
        ],
        [
            "Position(s)",
            "38 \u2013 204",
            "58 \u2013 58",
            "59 \u2013 204",
            "153 \u2013 174",
            "175 \u2013 223",
            "205 \u2013 223"
        ],
        [
            "Length",
            "167",
            "1",
            "146",
            "22",
            "49",
            "19"
        ],
        [
            "Description",
            "Missing in isoform 2 and isoform 3. 1 Publication Manually curated information that is based on statements in scientific articles for which there is no experimental support. More\u2026 Manual assertion based on opinion ini Ref.3 \"Identification of CTLA-4 isoforms produced by alternative splicing and their association with myasthenia gravis.\" Gu M., Kakoulidou M., Giscombe R., Pirskanen R., Lefvert A.K., Klareskog L., Wang X. Clin. Immunol. 128:374-381(2008) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3 AND 4), VARIANT ALA-17, ALTERNATIVE SPLICING.",
            "C \u2192 S in isoform 4. 1 Publication Manually curated information that is based on statements in scientific articles for which there is no experimental support. More\u2026 Manual assertion based on opinion ini Ref.3 \"Identification of CTLA-4 isoforms produced by alternative splicing and their association with myasthenia gravis.\" Gu M., Kakoulidou M., Giscombe R., Pirskanen R., Lefvert A.K., Klareskog L., Wang X. Clin. Immunol. 128:374-381(2008) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3 AND 4), VARIANT ALA-17, ALTERNATIVE SPLICING.",
            "Missing in isoform 4. 1 Publication Manually curated information that is based on statements in scientific articles for which there is no experimental support. More\u2026 Manual assertion based on opinion ini Ref.3 \"Identification of CTLA-4 isoforms produced by alternative splicing and their association with myasthenia gravis.\" Gu M., Kakoulidou M., Giscombe R., Pirskanen R., Lefvert A.K., Klareskog L., Wang X. Clin. Immunol. 128:374-381(2008) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3 AND 4), VARIANT ALA-17, ALTERNATIVE SPLICING.",
            "DPEPC\u2026VSSGL \u2192 AKEKKPSYNRGLCENAPNRA RM in isoform 5. 1 Publication Manually curated information that is based on statements in scientific articles for which there is no experimental support. More\u2026 Manual assertion based on opinion ini Ref.9 Oaks M.K. Submitted (FEB-1997) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 38-223 (ISOFORM 5).",
            "Missing in isoform 5. 1 Publication Manually curated information that is based on statements in scientific articles for which there is no experimental support. More\u2026 Manual assertion based on opinion ini Ref.9 Oaks M.K. Submitted (FEB-1997) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 38-223 (ISOFORM 5).",
            "PPTEP\u2026FIPIN \u2192 KEKKPSYNRGLCENAPNRAR M in isoform 3 and isoform 4. 1 Publication Manually curated information that is based on statements in scientific articles for which there is no experimental support. More\u2026 Manual assertion based on opinion ini Ref.3 \"Identification of CTLA-4 isoforms produced by alternative splicing and their association with myasthenia gravis.\" Gu M., Kakoulidou M., Giscombe R., Pirskanen R., Lefvert A.K., Klareskog L., Wang X. Clin. Immunol. 128:374-381(2008) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3 AND 4), VARIANT ALA-17, ALTERNATIVE SPLICING."
        ],
        [
            "Graphical view",
            "",
            "",
            "",
            "",
            "",
            ""
        ],
        [
            "Feature identifier",
            "VSP_041284",
            "VSP_041285",
            "VSP_041286",
            "VSP_047238",
            "VSP_047239",
            "VSP_041287"
        ],
        [
            "Actions",
            "Add BLAST",
            "",
            "Add BLAST",
            "Add BLAST",
            "Add BLAST",
            "Add BLAST"
        ]
    ],
    "pageTitle": "CTLA4 - Cytotoxic T-lymphocyte protein 4 precursor - Homo sapiens (Human)",
    "title": "",
    "url": "http://www.uniprot.org/uniprot/P16410",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042987402.78/warc/CC-MAIN-20150728002307-00245-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 804261427,
    "recordOffset": 804195570,
    "tableOrientation": "HORIZONTAL",
    "lastModified": "Wed, 22 Jul 2015 00:00:00 GMT",
    "textBeforeTable": "Alternative sequence VAR_072681 INVOLVEMENT IN ALPS5, VARIANT ALPS5 TRP-70. Cited for: Abstract] Europe PMC] [ PubMed] [ Nat. Med. 20:1410-1416(2014) [ Grimbacher B. , Kanariou M., Speckmann C., Ehl S., Rensing-Ehl A., Warnatz K., Rakhmanov M., Thimme R., Hasselblatt P., Emmerich F., Cathomen T., Backofen R., Fisch P., Seidl M., May A., Schmitt-Graeff A., Ikemizu S., Salzer U., Franke A., Sakaguchi S., Walker L.S., Sansom D.M., Seneviratne S. Niehues T., Dueckers G., Schmidt R.E., Witte T., Baumann U., Frede N., Unger S., Gruening B.A., Schaeffer A.A., Petersen B.S., Bulashevska A., Kennedy A., Wing J.B., Hou T.Z., Kenefeck R., Bode C., Schubert D., \"Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations.\"",
    "textAfterTable": "Sequence databases Select the link destinations: EMBL nucleotide sequence database<br/><a href='/database/22'>More..</a>EMBLi GenBank nucleotide sequence database<br/><a href='/database/28'>More..</a>GenBanki DNA Data Bank of Japan; a nucleotide sequence database<br/><a href='/database/14'>More..</a>DDBJi Links Updated L15006 mRNA. Translation: AAB59385.1. M74363 Genomic DNA. Translation: AAA52127.1. AF411058 Genomic DNA. Translation: AAL40932.1. AY792514 mRNA. Translation: AAV66331.1. AY999702 mRNA. Translation: AAY00166.1. DQ785106 mRNA. Translation: ABG85285.1. AF414120 mRNA. Translation: AAL07473.1. DQ357942 Genomic DNA. Translation: ABC67470.1. AC010138 Genomic DNA. Translation: AAX93176.1. BC074842 mRNA. Translation: AAH74842.1. BC074893 mRNA. Translation: AAH74893.1. AH002733 Genomic DNA. Translation:",
    "hasKeyColumn": false,
    "keyColumnIndex": -1,
    "headerRowIndex": 0
}